Search Results - "Gonzalez Rodriguez, CG"

5PSQ-119 A new pharmaceutical care programme for COVID-19 patients treated with Paxlovid®: Implementation and safety outcomes reported by Ferris Villanueva, M, Chamorro de Vega, E, Gonzalez Rodriguez, CG, Torroba Sanz, B, Vicente Valor, J, Herranz Alonso, A, Sanjurjo Sáez, M

“…Background and ImportanceThe COVID-19 pandemic has highlighted the important role that hospital pharmacists play in improving pharmacotherapy outcomes…”
Get full text

CP-066 Decreased inr after acenocoumarol and ombitasvir/paritaprevir/ritonavir co-administration by De Lorenzo-Pinto, A, Rodríguez-González, CG, Giménez-Manzorro, A, Manrique-Rodríguez, S, Ibáñez-García, S, Escudero-Vilaplana, V, Marzal-Alfaro, B, Herranz-Alonso, A, Revuelta-Herrero, JL, Sanjurjo-Sáez, M

“…BackgroundLimited data are available regarding co-administration of acenocoumarol with direct acting antiviral agents.PurposeWe report a case of a patient who…”
Get full text

5PSQ-033 Effectiveness of computerised decision support system-based intervention in antimicrobial use: the HIGEA project by Rodriguez-Gonzalez, CG, Chamorro-de Vega, E, Ibañez-Garcia, S, Martin-Barbero, ML, de la Rosa, JL, Herranz-Alonso, A, Sanjurjo-Saez, M

“…BackgroundClinical decision support systems (CDSS) can play an important role in facilitating antimicrobial stewardship programmes (ASP). However, the effects…”
Get full text

6ER-007 Off-label use of dalbavancin in gram-positive infections: effectiveness, safety and cost in clinical practice by Chamorro-De Vega, E, Rodriguez-Gonzalez, CG, Rochet, ME, Valerio, M, Olmedo, M, Herranz-Alonso, A, Munoz, P, Sanjurjo-Saez, M

“…BackgroundDalbavancin (DAL) has recently been approved to treat complicated skin and soft tissue infections. It enables treatments with a single IV…”
Get full text

DD-014 Staff satisfaction after the implementation of a robotic dispensing system in an outpatient pharmacy by Rodriguez-Gonzalez, CG, Herranz-Alonso, A, Gimenez-Manzorro, A, Escudero-Vilaplana, V, Ais-Larisgoitia, MA, Revuelta-Herrero, JL, Sanjurjo-Saez, M

“…BackgroundRobotic dispensing has demonstrated improvements in patient safety and workflow. However, there are no data on staff satisfaction after…”
Get full text

DD-012 A risk analysis method to evaluate the impact of robotic dispensing on patient safety by Rodriguez-Gonzalez, CG, Herranz-Alonso, A, Escudero-Vilaplana, V, Ais-Larisgoitia, MA, Ribed-Sanchez, A, Tovar-Pozo, M, Sanjurjo-Saez, M

“…BackgroundThe introduction of robotic dispensing systems in outpatient pharmacies (OP) has increased in recent years. However, there are no data available on…”
Get full text

CP-005 Association between medication adherence and effectiveness in the use of deferasirox for the treatment of transfusional iron overload in myelodysplastic syndrome by Escudero-Vilaplana, V, Mejias-Gomez, O, de la Encina, J Leal, Osorio-Prendes, S, Garcia-Gonzalez, X, Romero-Jimenez, RM, Rodriguez-Gonzalez, CG, Tovar-Pozo, M, Herranz-Alonso, A, Sanjurjo-Saez, M

“…BackgroundLiterature states the importance of medication adherence in the effectiveness of deferasirox for the treatment of transfusional iron overload in some…”
Get full text

CP-219 Effectiveness and safety of switching to dual antiretroviral therapy in a treatment experienced HIV cohort by Martinez, C Ruiz, Rodriguez-Gonzalez, CG, Ribed, A, Revuelta, JL, Tovar-Pozo, M, Monje, B, Ortega-Navarro, C, Garcia-Gonzalez, X, Alonso, A Herranz, Saez, M Sanjurjo

“…BackgroundLong term adverse effects, expense and difficulty of adherence to antiretroviral therapy (ART) have led to the study of simpler maintenance…”
Get full text

CP-212 Effectiveness and safety of new direct acting antivirals for the treatment of hepatitis C infection: Preliminary data in a coinfected HIV/HCV population by Rodriguez-Gonzalez, CG, Vega, E Chamorro-De, Gimenez-Manzorro, A, Ruiz-Martinez, C, Marzal-Alfaro, B, Collado-Borrell, R, Sarobe-Gonzalez, C, Revuelta-Herrero, JL, Herranz-Alonso, A, Sanjurjo-Saez, M

“…BackgroundIn 2015, the development of well tolerated and highly effective direct acting antivirals (DAAs) for hepatitis C virus (HCV) dramatically changed the…”
Get full text

3PC-023 A risk analysis method to evaluate the impact of a chemotherapy compounding workflow management system on cancer patients’ safety by Marzal Alfaro, B, Rodríguez-González, CG, Escudero-Vilaplana, V, Revuelta-Herrero, JL, Ibáñez-Garcia, S, García Martín, E, González-Haba, E, Iglesias-Peinado, I, Herranz, A, Sanjurjo-Saez, M

“…BackgroundThe implementation of technology for chemotherapy compounding is recommended by several organisations to improve patient safety. However, a careful…”
Get full text

5PSQ-067 Analysis of antineoplastic drugs preparation errors as a first step to improve the quality of the process by Alfaro, B Marzal, Escudero-Vilaplana, V, Rodríguez-González, CG, Peña, E González-Haba, García-González, X, Ibañez-García, S, García-Moreno, FJ, Ortega-Navarro, C, Iglesias-Peinado, I, Herranz, A, Sanjurjo-Saez, M

“…BackgroundAntineoplastic preparation presents unique safety concerns because of its toxicity and narrow therapeutic window. Moreover, the antineoplastic use…”
Get full text